HOME
ABOUT
Timeline
Team
Commitment to Canada
PRODUCTS
Pipeline
SERVICES
Commercial Market Access
Process Development
Automation Design
Clinical & Commercial Manufacturing
NEWSROOM
CAREERS
CONTACT
NEWSROOM
Newsroom
New vaccine targets pneumonia, blood poisoning, meningitis among children in Canada's North
By InventVacc
•
January 30, 2022
NRC recently gave the licence to manufacture the Type A vaccine to Vancouver-based InventVacc Biologicals Inc.
Leading the way with Hia: Vaccine for the deadly infection gains traction
By InventVacc
•
January 29, 2022
Licensed to InventVacc Biologicals Inc. for manufacturing in preparation for clinical trials
Vaccine to prevent deadly infections in Canada’s North reaches manufacturing milestone
By InventVacc
•
January 29, 2022
InventVacc is pleased to contribute over four decades of vaccine manufacturing expertise to the manufacturing of the Hia vaccine.
High-quality, cost-effective and sustainable global vaccine producer.
Navigation
HOME
ABOUT
PRODUCTS
SERVICES
NEWSROOM
CAREERS
CONTACT
Terms of use
Privacy Policy
©
Copyright
InventVacc Biologicals Inc
Share by: